ILLUMINA INC (ILMN)
US4523271090 - Common Stock
ILLUMINA INC
NASDAQ:ILMN (4/15/2024, 7:11:50 PM)
After market: 121.3 +0.14 (+0.12%)121.16
-5.91 (-4.65%)
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 11,500 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122
P: 18582024500
CEO: Francis A. deSouza
Employees: 11500
Website: https://www.illumina.com
ILMN News
10 hours ago - ChartmillTop S&P500 movers in Monday's sessionCurious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
12 hours ago - ChartmillWhat's going on in today's session: S&P500 moversWondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.
14 hours ago - ChartmillWondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.Gapping S&P500 stocks in Monday's session
4 days ago - Illumina, Inc.Illumina's planned divestment of GRAIL approved by the European Commission/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has received approval of its...
4 days ago - Yahoo FinanceUPDATE 1-EU approves Illumina's plan to divest cancer test maker GrailU.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail has received the green light from EU antitrust regulators which blocked the deal two years ago. Illumina jumped the gun in 2021 when it completed the $7.1-billion acquisition before first securing EU regulatory approval. That prompted the European Commission, which acts as the competition enforcer in the 27-country European Union, to order the company to keep Grail separate from Illumina.
6 days ago - Yahoo FinanceUPDATE 2-Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeedIllumina said on Tuesday Chief Financial Officer Joydeep Goswami will leave the gene sequencing company and be succeeded by former Summit Therapeutics' executive Ankur Dhingra. Goswami, who has more than two decades of experience in the life sciences industry, was the CFO since early 2023 and will serve as an adviser till June 30, the company said. Prior to Summit, Dhingra was the CFO at medical test maker CareDx.
ILMN Twits
Here you can normally see the latest stock twits on ILMN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
